tiprankstipranks
Trending News
More News >
Runway Growth Finance Corp (RWAY)
NASDAQ:RWAY
US Market

Runway Growth Finance Corp (RWAY) Earnings Dates, Call Summary & Reports

Compare
322 Followers

Earnings Data

Report Date
May 12, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.33
Last Year’s EPS
0.42
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 12, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a generally constructive outlook centered on strategic actions that strengthen the company’s balance sheet and diversify the portfolio — particularly the pending SWK acquisition, strong liquidity, active originations, and improvements in operating efficiency. These positives were tempered by near-term earnings pressure from normalized prepayment income, lower quarter-over-quarter yield and NII declines, and timing-related softness tied to the SWK close and debt redemptions. Overall, management emphasized conservative underwriting, low nonaccruals, and concrete actions (debt issuance, note redemptions, and expected accretion from SWK) to stabilize and modestly enhance long-term earnings power.
Company Guidance
The company guided that the SWK Holdings acquisition is expected to close in early April (around April 6) and will add a portfolio of 13 loans with ~ $235M fair value (total portfolio yield ~14%, debt-only ~16%), driving post-close leverage to just under 1.2x (targeting a 1.2x–1.3x run rate, generally not above 1.35x) and reducing average position size to $23.5M (2.2% of the portfolio) from $30.3M (3.1%), with run‑rate net investment income (NII) accretion in the mid‑single digits and modest ROE expansion and improved dividend coverage; they warned of Q1 earnings softness due to the slight timing delay and a $0.02 one‑time headwind from redemption of 8% and partial 7.5% 2027 notes. Key recent metrics referenced: Q4 total investment income $30.0M and NII $11.6M ($0.32 per share) with a base dividend of $0.33 and ~ $0.65 spillover income for year‑end; 2025 dollar‑weighted loan yield 14.2% (down from 16.8% sequentially and 14.7% year‑over‑year); total investment portfolio fair value $927.4M (‑2%), NAV $13.42 (‑1%), net assets $484.9M; liquidity $395.2M with $377M borrowing capacity; unfunded commitments $145.5M ( $122.8M debt, $22.7M JV equity; $32.4M milestone‑eligible); one nonaccrual (cost $4.8M, FV $2.4M, 0.25% of portfolio); and capital actions including a $103.25M 2031 note offering at 7.25% and redemptions of 7.5%/8% 2027 notes.
Investment Income and NII Delivered
Generated total investment income of $30.0M and net investment income (NII) of $11.6M in the fourth quarter, delivering $0.32 of NII per share and maintaining a base dividend of $0.33 per share with approximately $0.65 per share of spillover income at year-end.
Active Origination and Portfolio Additions
Completed seven investments in Q4 totaling $42.9M across technology, health care, and select consumer sectors (including a $20M mobility deal, $10M consumer SPV, $20M commitment to Shield Therapeutics with $2M funded at close, and $10.9M of follow-ons to existing portfolio companies).
SWK Acquisition Expected to Drive Diversification and Accretion
Announced acquisition of SWK Holdings expected to close in early April; SWK bring ~13 loans (~$235M fair value), equity positions and royalties, and will increase health care and life sciences exposure. Management expects run-rate NII accretion in the mid-single digits, modest ROE expansion, improved dividend coverage, and reduced average position size to $23.5M (2.2% of portfolio) from $30.3M (3.1%), a ~22% reduction in average position size.
Strong Liquidity and Financing Flexibility
Available liquidity of $395.2M as of 12/31/2025 (including borrowing capacity of $377M) and launched an underwritten public offering of $103.25M unsecured notes due Feb 2031 at 7.25%, while redeeming higher-coupon near-term notes to extend the debt maturity ladder and lower cost of funds.
Conservative Credit Profile and Low Nonaccruals
Portfolio remains almost exclusively first-lien senior secured loans with only one loan on nonaccrual (Domingo Healthcare) with a cost basis of $4.8M and fair value of $2.4M (50% of cost), representing just 0.25% of the total investment portfolio at fair value.
Operating Efficiency and Loss Reduction
Total operating expenses decreased to $18.4M from $21.0M (-12.4%), and net realized losses on investments improved to $0.377M from $1.3M (approximately -71%), showing tighter expense control and fewer realized losses.
Stable NAV, Modest Asset Base Contraction
Net assets of $484.9M and NAV per share of $13.42 as of 12/31/2025, a modest NAV decline of ~1% from $13.55. Total investment portfolio fair value was $927.4M, down 2% from $946.0M year-over-year.
Pipeline Momentum and Sourcing Benefits from BC Partners
Management reported a stronger origination pipeline year-over-year, citing greater deal flow and enhanced sourcing from BC Partners and expected additive sourcing from SWK, with measured optimism for 2026 despite seasonal Q1 cadence.

Runway Growth Finance Corp (RWAY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

RWAY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 12, 2026
2026 (Q1)
0.33 / -
0.42
Mar 12, 2026
2025 (Q4)
0.35 / 0.32
0.39-17.95% (-0.07)
Nov 06, 2025
2025 (Q3)
0.40 / 0.43
0.414.88% (+0.02)
Aug 07, 2025
2025 (Q2)
0.39 / 0.38
0.372.70% (+0.01)
May 12, 2025
2025 (Q1)
0.37 / 0.42
0.46-8.70% (-0.04)
Mar 20, 2025
2024 (Q4)
0.42 / 0.39
0.45-13.33% (-0.06)
Nov 12, 2024
2024 (Q3)
0.45 / 0.41
0.54-24.07% (-0.13)
Aug 08, 2024
2024 (Q2)
0.44 / 0.37
0.49-24.49% (-0.12)
May 07, 2024
2024 (Q1)
0.45 / 0.46
0.452.22% (+0.01)
Mar 07, 2024
2023 (Q4)
0.49 / 0.45
0.450.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

RWAY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 12, 2026
$7.16
Nov 06, 2025
$8.99$9.16+1.86%
Aug 07, 2025
$9.73$9.83+1.02%
May 12, 2025
$8.15$8.68+6.47%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Runway Growth Finance Corp (RWAY) report earnings?
Runway Growth Finance Corp (RWAY) is schdueled to report earning on May 12, 2026, After Close (Confirmed).
    What is Runway Growth Finance Corp (RWAY) earnings time?
    Runway Growth Finance Corp (RWAY) earnings time is at May 12, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is RWAY EPS forecast?
          RWAY EPS forecast for the fiscal quarter 2026 (Q1) is 0.33.